The Indian Space Research Organisation (ISRO) Chief S Somnath was diagnosed with cancer on the monumental day of India’s Aditya-L1 mission launch. In an interview with Tarmak Media House, Somnath confirmed the detection of a growth during a routine scan, unveiling his unforeseen health setback.
“There were some health issues during Chandrayaan-3 mission launch. However, it was not clear to me at the time, I did not have a clear understanding about it,” Somnath said. Somnath informed that he received the diagnosis on the same day the Aditya-L1 mission was launched.
On September 2, 2023, as India’s inaugural space-based solar observatory, Aditya L1, set off on its mission to study the Sun, S Somnath underwent a routine scan that revealed a growth in his stomach.
Cancer detection ‘shocking’ for Somnath’s family
The news came as a surprise not only to him but also to his family and colleagues, who have been supporting him during this difficult time. This unforeseen revelation prompted him to travel to Chennai for further scans, which confirmed the existence of a hereditary illness. Within a matter of days, it became evident that he faced a substantial health obstacle alongside his professional duties.
S Somnath subsequently underwent surgery followed by chemotherapy. “It was a shock for the family. But now, I perceive cancer and its treatment as a solution. I was uncertain about a complete cure at the time, I was undergoing the process,” he said. Speaking about his experience with Tarmak Media House, he said, “I was uncertain about a complete cure at the time, I was undergoing the process.”
Somnath’s remarkable recovery
However, his recovery has been remarkable. Despite spending only four days in the hospital, he promptly resumed his responsibilities at ISRO, returning to work on the fifth day without experiencing any discomfort.
“I will be undergoing regular checkups and scans. But, now I am completely cured, and have resumed my duties,” Somnath said.
